Professional Documents
Culture Documents
Transmission of HIV
Sharing needles whether used illegally for drugs or legally Unprotected sex the virus can enter the bloodstream of a partner through breaks in the skin or lesions caused by other infections (usually other STIs). Infection can also occur via oral sex, though this is rare. Direct blood-to-blood transfer through cuts and grazes. Maternal transmission from mother to unborn child or in breast milk. Risk occurs in last few weeks of pregnancy, mostly around the birth itself, when mingling of infant and maternal blood is likely to happen.
o HIV antibodies appear in the blood after 3-12 weeks. o Infected person may experience symptoms such as fever, sweats, headache, sore throat and swollen lymph nodes, or they may have no symptoms. o There is rapid replication of the virus and loss of T helper cells. o After a few weeks, infected T helper cells are recognised and then destroyed by T killer cells this greatly reduces the rate of virus replication but doesnt totally eliminate it.
o Virus continues to reproduce rapidly but numbers are kept in check by immune system. o There may be no symptoms during this phase, but there can be an increasing tendency to suffer colds or other infections, which are slow to go away. o Dormant diseases like shingles and TB can reactivate. o Chronic phase can last many years, especially in fit young people who lead healthy lifestyles combined with drug treatment.
o Eventually, the increased number of viruses in circulation (viral load) and a declining number of T helper cells indicates the onset of AIDS, the disease phase. o During this phase, the decrease in number of T helper cells leaves the immune system vulnerable to other diseases.
Treating AIDS
There is no treatment to get rid of HIV, but there are drugs available that reduce the production of more viruses. These are known as antiretroviral drugs. There are 2 main types: Reverse transcriptase inhibitors which prevent the viral RNA from making DNA for integration into the hosts genome. Protease inhibitors which inhibit the proteases that catalyse the cutting of larger proteins into small polypeptides for use in the construction of new viruses.